Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | MDM2 proto-oncogene, E3 ubiquitin protein ligase | Starlite/ChEMBL | References |
Homo sapiens | cytochrome P450, family 3, subfamily A, polypeptide 4 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | cytochrome P450 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 502 aa | 492 aa | 24.2 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Chlamydia trachomatis | DNA topoisomerase I | 0.0013 | 0.8119 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0013 | 0.8119 | 0.8119 |
Trypanosoma brucei | cytochrome P450, putative | 0.0015 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.8119 | 1 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0013 | 0.8119 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0013 | 0.8119 | 0.8119 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0013 | 0.8119 | 1 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0013 | 0.8119 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0013 | 0.8119 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.8119 | 1 |
Trypanosoma cruzi | cytochrome P450, putative | 0.0015 | 1 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0013 | 0.8119 | 0.5 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0013 | 0.8119 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0013 | 0.8119 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0015 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.8119 | 1 |
Brugia malayi | Cytochrome P450 family protein | 0.0015 | 1 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0013 | 0.8119 | 1 |
Chlamydia trachomatis | SWIB complex protein | 0.0013 | 0.8119 | 0.5 |
Brugia malayi | brahma associated protein 60 kDa | 0.0013 | 0.8119 | 0.8119 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.8119 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0013 | 0.8119 | 1 |
Loa Loa (eye worm) | brahma associated protein | 0.0013 | 0.8119 | 0.8119 |
Schistosoma mansoni | hypothetical protein | 0.0013 | 0.8119 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0015 | 1 | 0.5 |
Onchocerca volvulus | 0.0013 | 0.8119 | 1 | |
Schistosoma mansoni | brg-1 associated factor | 0.0013 | 0.8119 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0015 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0011 | 0.5833 | 0.5833 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0013 | 0.8119 | 1 |
Leishmania major | cytochrome p450-like protein | 0.0015 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0013 | 0.8119 | 0.8119 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0013 | 0.8119 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 41 nM | Binding affinity to HDM2 (unknown origin) by fluorescence polarization peptide displacement assay | ChEMBL. | 24900882 |
IC50 (ADMET) | < 0.3 uM | Inhibition of CYP3A4 (unknown origin) pre-incubated with enzyme | ChEMBL. | 24900882 |
IC50 (functional) | = 1 uM | Antiproliferative activity against human SJSA1 cells expressing wild type p53 protein by cell Titer-Glo assay | ChEMBL. | 24900882 |
IC50 (ADMET) | = 2.1 uM | Inhibition of CYP3A4 (unknown origin) co-incubated with enzyme | ChEMBL. | 24900882 |
IC50 (ADMET) | > 30 uM | Inhibition of CYP2D6 (unknown origin) co-incubated with enzyme | ChEMBL. | 24900882 |
IC50 (ADMET) | > 30 uM | Inhibition of CYP2C9 (unknown origin) co-incubated with enzyme | ChEMBL. | 24900882 |
IC50 (ADMET) | > 30 uM | Inhibition of CYP2D6 (unknown origin) pre-incubated with enzyme | ChEMBL. | 24900882 |
IC50 (ADMET) | > 30 uM | Inhibition of CYP2C9 (unknown origin) pre-incubated with enzyme | ChEMBL. | 24900882 |
Ratio IC50 (ADMET) | = 7 | Ratio of IC50 for CYP3A4 (unknown origin) co-incubated with enzyme to IC50 for CYP3A4 (unknown origin) pre-incubated with enzyme | ChEMBL. | 24900882 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 24900882 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.